Published in Eur Urol on November 01, 2014
Current Practice Patterns Among Members of the American Urological Association for Male Genitourinary Lichen Sclerosus. Urology (2016) 1.38
Re: Oliver W. Hakenberg, Eva M. Compérat, Suks Minhas, Andrea Necchi, Chris Protzel, Nick Watkin. EAU Guidelines on Penile Cancer: 2014 Update. Eur Urol 2015;67:142-50. Eur Urol (2014) 1.07
Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer. BMC Cancer (2016) 0.83
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma. Int J Mol Sci (2016) 0.82
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol (2016) 0.81
Penile preserving and reconstructive surgery in the management of penile cancer. Nat Rev Urol (2016) 0.79
Extent of pelvic lymph node dissection in penile cancer may impact survival. World J Urol (2015) 0.78
Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines. BMC Urol (2015) 0.76
Penile cancer: Perspective from a Canadian tertiary care centre. Can Urol Assoc J (2015) 0.75
Penile cancer: Welcome changes in disease management and remaining challenges. Nat Rev Urol (2016) 0.75
Investigating the role of SPECT/CT in dynamic sentinel lymph node biopsy for penile cancers. Eur J Nucl Med Mol Imaging (2017) 0.75
Clinicopathologic and outcome features of superficial high-grade and deep low-grade squamous cell carcinomas of the penis. Springerplus (2015) 0.75
Penile metastasis from primary transitional cell carcinoma of the bladder sparing the urethra. Can Urol Assoc J (2016) 0.75
Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer. Investig Clin Urol (2017) 0.75
Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma. Oncoimmunology (2016) 0.75
A study on the value of computer-assisted assessment for SPECT/CT-scans in sentinel lymph node diagnostics of penile cancer as well as clinical reliability and morbidity of this procedure. Cancer Imaging (2016) 0.75
The importance of extranodal extension in penile cancer: a meta-analysis. BMC Cancer (2015) 0.75
Re: Role of Surgical Resection for Refractory Germ Cell Tumors. J Urol (2016) 0.75
Re: EAU Guidelines on Penile Cancer: 2014 Update. J Urol (2016) 0.75
More precise prediction in Chinese patients with penile squamous cell carcinoma: protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticator. Oncotarget (2017) 0.75
Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach. Eur J Nucl Med Mol Imaging (2016) 0.75
Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study. J Cancer Res Clin Oncol (2016) 0.75
Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma. Sci Rep (2017) 0.75
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol (2013) 7.48
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol (2010) 7.20
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol (2013) 6.54
EAU guidelines on prostate cancer. Eur Urol (2007) 6.30
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol (2013) 4.89
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol (2013) 4.65
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol (2013) 4.58
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol (2013) 2.93
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet (2016) 2.84
European Association of Urology guidelines on priapism. Eur Urol (2013) 2.41
EAU guidelines on penile curvature. Eur Urol (2012) 2.40
Guidelines on Testicular Cancer: 2015 Update. Eur Urol (2015) 2.11
EAU guidelines on surgical treatment of urinary incontinence. Eur Urol (2012) 2.05
EAU guidelines on chronic pelvic pain. Eur Urol (2009) 1.97
EAU guidelines on testicular cancer: 2011 update. Eur Urol (2011) 1.96
EAU guidelines on prostate cancer. Eur Urol (2005) 1.88
EAU guidelines on vesicoureteral reflux in children. Eur Urol (2012) 1.76
Early detection of prostate cancer: European Association of Urology recommendation. Eur Urol (2013) 1.71
EAU guidelines on urological trauma. Eur Urol (2005) 1.70
[EAU guidelines on prostate cancer]. Actas Urol Esp (2009) 1.68
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol (2004) 1.47
EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol (2001) 1.46
The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol (2013) 1.45
EAU guidelines on iatrogenic trauma. Eur Urol (2012) 1.34
EAU Guidelines on Urethral Trauma. Eur Urol (2010) 1.29
EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol (2012) 1.23
EAU guidelines on renal transplantation. Eur Urol (2005) 1.22
EAU guidelines on primary urethral carcinoma. Eur Urol (2013) 1.22
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol (2008) 1.21
EAU Guidelines on Penile Cancer. Eur Urol (2004) 1.19
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas Urol Esp (2011) 1.19
EAU guidelines on paediatric urology. Eur Urol (2001) 1.16
EAU guidelines on robotic and single-site surgery in urology. Eur Urol (2013) 1.13
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic. Eur Urol (2020) 1.09
[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines]. Actas Urol Esp (2012) 1.02
EAU guidelines on penile cancer. Eur Urol (2002) 0.99
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol (2017) 0.99
EAU guidelines on chronic pelvic pain. Eur Urol (2004) 0.99
EAU guidelines on surgical treatment of urinary incontinence. Actas Urol Esp (2013) 0.92
Guidelines on erectile dysfunction. Eur Urol (2002) 0.89
Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol (2014) 0.87
[EAU Guidelines on Urinary Incontinence]. Actas Urol Esp (2011) 0.86
[EAU Recommendations 2001. "Guidelines on bladder cancer"]. Prog Urol (2002) 0.81
Guidelines on renal cell cancer. Eur Urol (2001) 0.81
[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma]. Actas Urol Esp (2010) 0.79
The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016. Eur Urol (2016) 0.78
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant (2015) 0.77
[European Association of Urology guidelines on laser technologies]. Actas Urol Esp (2012) 0.76
Surgical Management of Penile Carcinoma in Situ: Results from an International Collaborative Study and Review of the Literature. BJU Int (2017) 0.75
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer. BJU Int (2020) 0.75
Re: Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. Eur Urol (2017) 0.75
Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. Eur Urol (2016) 0.75
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. Eur Urol Focus (2017) 0.75
The Role of Urodynamics in the Evaluation of Urinary Incontinence: The European Association of Urology Recommendations in 2016. Eur Urol (2016) 0.75
Glansectomy as Primary Management of Penile Squamous Cell Carcinoma: an International Study Collaboration. Urology (2017) 0.75
Editorial Comment. J Urol (2016) 0.75
Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy. Clin Genitourin Cancer (2013) 0.75
Is minimally invasive inguinal node dissection the way forward? BJU Int (2017) 0.75
Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib. Invest New Drugs (2017) 0.75